Case report: Hashimoto’s thyroiditis after CD19 chimeric antigen receptor T-cell therapy

Chimeric antigen receptor (CAR)-T cell therapy is a novel cell therapeutic approach that is increasingly being used to treat patients with relapsed refractory B-cell lymphoma. Despite the efficacy of CAR T cell therapy, it has various adverse effects that can affect any organ in the body. The applic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Panpan, Xia, Yongming, Lei, Wen, Zhong, Shuhan, Jiang, Huawei, Ren, Lingling, Qian, Wenbin, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646589/
https://www.ncbi.nlm.nih.gov/pubmed/36389794
http://dx.doi.org/10.3389/fimmu.2022.995496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646589/
https://www.ncbi.nlm.nih.gov/pubmed/36389794
http://dx.doi.org/10.3389/fimmu.2022.995496

Ejemplares similares